Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
RBD1119 · 1 trial · 1 indication
To measure the effect of RBD1119 on blood coagulation factor XI activity.
Change from baseline in blood coagulation factor XI activity.
| Arm | Type | Description |
|---|---|---|
| Low-dose group | EXPERIMENTAL | - |
| Medium-dose group | EXPERIMENTAL | - |
| High-dose group | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| RBD1119 | DRUG | RBD1119, active drug |
| Placebo | DRUG | Placebo |
Inclusion Criteria: 1. Willing and able to give written informed consent for participation in the trial. 2. Male or female participants age ≥50 years. For male participants, those who are potent and sexually active with a female partner of childbearing potential must agree to use effective male con...